Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Psoriasis Patients”

412 trials

Showing 20 of 412 results

Post-approval studies (Phase 4)Study completedNCT03506477
What this trial is testing

Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color

Who this might be right for
Plaque PsoriasisPsoriasis
Icahn School of Medicine at Mount Sinai 25
Not applicableStudy completedNCT04203693
What this trial is testing

Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 331
Not applicableStudy completedNCT01555606
What this trial is testing

An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Janssen Biotech, Inc. 108
Large-scale testing (Phase 3)Looking for participantsNCT06842199
What this trial is testing

Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis Patients
Beijing InnoCare Pharma Tech Co., Ltd. 383
Post-approval studies (Phase 4)Study completedNCT00581100
What this trial is testing

Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis

Who this might be right for
Nail PsoriasisPlaque Psoriasis
Wyeth is now a wholly owned subsidiary of Pfizer 136
Post-approval studies (Phase 4)Study completedNCT00161655
What this trial is testing

Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis

Who this might be right for
PsoriasisArthritis, Psoriatic
Wyeth is now a wholly owned subsidiary of Pfizer 60
Testing effectiveness (Phase 2)Study completedNCT02932878
What this trial is testing

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries, Inc. 16
Early research (Phase 1)Study completedNCT00871598
What this trial is testing

BTT1023 in Psoriasis

Who this might be right for
Plaque Psoriasis
Biotie Therapies Corp. 26
Post-approval studies (Phase 4)WithdrawnNCT05499416
What this trial is testing

Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis

Who this might be right for
Psoriasis VulgarisActive Psoriatic Arthritis
Innovaderm Research Inc.
Large-scale testing (Phase 3)Study completedNCT00141921
What this trial is testing

Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis

Who this might be right for
Pediatric Plaque Psoriasis
Amgen 182
Testing effectiveness (Phase 2)Study completedNCT03230292
What this trial is testing

Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma SRL 43
Post-approval studies (Phase 4)Study completedNCT01556672
What this trial is testing

Adalimumab-psoriasis and Small Bowel Lesions

Who this might be right for
Plaque PsoriasisCrohn's Disease
Innovaderm Research Inc. 100
Testing effectiveness (Phase 2)Study completedNCT06109818
What this trial is testing

Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Beijing InnoCare Pharma Tech Co., Ltd. 129
Large-scale testing (Phase 3)Study completedNCT03818035
What this trial is testing

Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag International NV 880
Large-scale testing (Phase 3)Study completedNCT00258713
What this trial is testing

A 36-Week Extension to Protocol ISA04-03

Who this might be right for
Psoriasis
Aurinia Pharmaceuticals Inc. 309
Large-scale testing (Phase 3)UnknownNCT06299982
What this trial is testing

An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsO

Who this might be right for
Plaque Psoriasis Patients
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 750
Not applicableStudy completedNCT01202565
What this trial is testing

Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 506
Testing effectiveness (Phase 2)Study completedNCT01043393
What this trial is testing

Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 24
Not applicableStudy completedNCT02935582
What this trial is testing

PSOREAL - Managing PSOriasis in the REAL World

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 1,214
Testing effectiveness (Phase 2)Study completedNCT01899729
What this trial is testing

A 12-week Dose-Ranging Trial in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Idera Pharmaceuticals, Inc. 46
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation